Maxor

Equity in healthcare series – part 9 Millions of Americans now live in areas with limited or no access to […]

Equity in healthcare series – part 8 Mental health has been gaining attention in recent years, but for many Americans

Join us for the latest in our series, AI in healthcare. Learn how AI is transforming the way we track,

by Howard Hall, SVP Enterprise Growth, Maxor The purpose of the 340B Drug Pricing Program continues to spark debate, particularly

Equity in healthcare series – part 7 May marks Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Heritage Month—a time

Equity in healthcare series – part 6 Clinical trials are essential to advancing medical knowledge and improving patient outcomes. According

Drug shortages remain a significant issue in the United States in 2025. As of April 17, there are 270 active

Equity in healthcare series – part 5 The words we use matter—especially in healthcare. Language shapes perceptions, influences behavior, and

Autoimmune diseases occur when the immune system—which normally defends the body against illness—mistakenly attacks healthy cells, tissues, or organs. This

As the 340B program faces unprecedented pressure from legislators, manufacturers, and courts, health system leaders must prepare for a new